The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism
Melanie A. Paquette, Katherine Foley, Elizabeth G. Brudney, Charles K. Meshul, Steven W. Johnson, S. Paul BergerVolume:
204
Language:
english
Pages:
3
DOI:
10.1007/s00213-009-1522-7
Date:
May, 2009
File:
PDF, 259 KB
english, 2009